Charlotte Kawecki
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: November 24, 2020
Serpins, New Therapeutic Targets for Hemophilia.
Journal: Thrombosis and haemostasis
Published: September 28, 2020
von Willebrand Factor Is a Critical Mediator of Deep Vein Thrombosis in a Mouse Model of Diet-Induced Obesity.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: September 24, 2020
Receptor for Advanced Glycation End Products is Involved in Platelet Hyperactivation and Arterial Thrombosis during Chronic Kidney Disease.
Journal: Thrombosis and haemostasis
Published: July 30, 2020
Development and characterization of single-domain antibodies neutralizing protease nexin-1 as tools to increase thrombin generation.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 08, 2020
A hemophilia A mouse model for the in vivo assessment of emicizumab function.
Journal: Blood
Published: November 27, 2019
Single-domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors.
Journal: EMBO molecular medicine
Published: August 14, 2019
A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 18, 2019
Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidence.
Journal: Haematologica
Published: September 13, 2018
Identification of CD36 as a new interaction partner of membrane NEU1: potential implication in the pro-atherogenic effects of the elastin receptor complex.
Journal: Cellular and molecular life sciences : CMLS
Published: March 13, 2018
Last Updated: 09/26/2026